Global Human Milk Oligosaccharides (HMO) Market Analysis and Forecast 2024-2030
Summary
Human milk oligosaccharides (HMOs) are a family of structurally diverse unconjugated glycan’s that are found in and unique to human breast milk, despite not actually being digestible by human infants. HMOs function as a prebiotic helping to establish commensal bacteria. HMOs also function as anti-adhesives that help prevent the attachment of microbial pathogens to mucosal surfaces. Human milk oligosaccharides are manufactured through numerous processes which involve the use of several chemicals, enzymes or microbes. The technology used for manufacturing of human milk oligosaccharides is very complex and expensive, thus restricting their large-scale production. Major players have been increasing investing increasingly on R&D for low-cost production and the introduction of effective technologies for product synthesis.
According to APO Research, The global Human Milk Oligosaccharides (HMO) market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Human Milk Oligosaccharides (HMO) is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Asia-Pacific market for Human Milk Oligosaccharides (HMO) is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The China market for Human Milk Oligosaccharides (HMO) is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Europe market for Human Milk Oligosaccharides (HMO) is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The major global manufacturers of Human Milk Oligosaccharides (HMO) include Abbott, Inbiose, Glycom, Chr. Hansen (Jennewein), Elicityl SA, ZuChem and Dextra Laboratories, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report presents an overview of global market for Human Milk Oligosaccharides (HMO), sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Human Milk Oligosaccharides (HMO), also provides the sales of main regions and countries. Of the upcoming market potential for Human Milk Oligosaccharides (HMO), and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Human Milk Oligosaccharides (HMO) sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Human Milk Oligosaccharides (HMO) market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Human Milk Oligosaccharides (HMO) sales, projected growth trends, production technology, application and end-user industry.
Human Milk Oligosaccharides (HMO) segment by Company
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Human Milk Oligosaccharides (HMO) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Human Milk Oligosaccharides (HMO) and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Human Milk Oligosaccharides (HMO).
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Sales (consumption), revenue of Human Milk Oligosaccharides (HMO) in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 4: Detailed analysis of Human Milk Oligosaccharides (HMO) manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Human Milk Oligosaccharides (HMO) sales, revenue, price, gross margin, and recent development, etc.
Chapter 8: North America (US & Canada) by type, by application and by country, sales, and revenue for each segment.
Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.
Chapter 10: China type, by application, sales, and revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.
Chapter 12: Middle East, Africa, and Latin America type, by application and by country, sales, and revenue for each segment.
Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 14: The main concluding insights of the report.
Human milk oligosaccharides (HMOs) are a family of structurally diverse unconjugated glycan’s that are found in and unique to human breast milk, despite not actually being digestible by human infants. HMOs function as a prebiotic helping to establish commensal bacteria. HMOs also function as anti-adhesives that help prevent the attachment of microbial pathogens to mucosal surfaces. Human milk oligosaccharides are manufactured through numerous processes which involve the use of several chemicals, enzymes or microbes. The technology used for manufacturing of human milk oligosaccharides is very complex and expensive, thus restricting their large-scale production. Major players have been increasing investing increasingly on R&D for low-cost production and the introduction of effective technologies for product synthesis.
According to APO Research, The global Human Milk Oligosaccharides (HMO) market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Human Milk Oligosaccharides (HMO) is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Asia-Pacific market for Human Milk Oligosaccharides (HMO) is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The China market for Human Milk Oligosaccharides (HMO) is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Europe market for Human Milk Oligosaccharides (HMO) is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The major global manufacturers of Human Milk Oligosaccharides (HMO) include Abbott, Inbiose, Glycom, Chr. Hansen (Jennewein), Elicityl SA, ZuChem and Dextra Laboratories, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report presents an overview of global market for Human Milk Oligosaccharides (HMO), sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Human Milk Oligosaccharides (HMO), also provides the sales of main regions and countries. Of the upcoming market potential for Human Milk Oligosaccharides (HMO), and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Human Milk Oligosaccharides (HMO) sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Human Milk Oligosaccharides (HMO) market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Human Milk Oligosaccharides (HMO) sales, projected growth trends, production technology, application and end-user industry.
Human Milk Oligosaccharides (HMO) segment by Company
- Abbott
- Inbiose
- Glycom
- Chr. Hansen (Jennewein)
- Elicityl SA
- ZuChem
- Dextra Laboratories
- 2'-FL & 3-FL
- Sialyllactose
- LNT & LNnT
- Infant Formula
- Functional Food & Beverages
- Food/Medical Supplements
- Others
- North America
- U.S.
- Canada
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Australia
- China Taiwan
- Indonesia
- Thailand
- Malaysia
- Latin America
- Mexico
- Brazil
- Argentina
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Human Milk Oligosaccharides (HMO) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Human Milk Oligosaccharides (HMO) and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Human Milk Oligosaccharides (HMO).
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Sales (consumption), revenue of Human Milk Oligosaccharides (HMO) in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 4: Detailed analysis of Human Milk Oligosaccharides (HMO) manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Human Milk Oligosaccharides (HMO) sales, revenue, price, gross margin, and recent development, etc.
Chapter 8: North America (US & Canada) by type, by application and by country, sales, and revenue for each segment.
Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.
Chapter 10: China type, by application, sales, and revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.
Chapter 12: Middle East, Africa, and Latin America type, by application and by country, sales, and revenue for each segment.
Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 14: The main concluding insights of the report.
1 MARKET OVERVIEW
1.1 Product Definition
1.2 Human Milk Oligosaccharides (HMO) Market by Type
1.2.1 Global Human Milk Oligosaccharides (HMO) Market Size by Type, 2019 VS 2023 VS 2030
1.2.2 2'-FL & 3-FL
1.2.3 Sialyllactose
1.2.4 LNT & LNnT
1.3 Human Milk Oligosaccharides (HMO) Market by Application
1.3.1 Global Human Milk Oligosaccharides (HMO) Market Size by Application, 2019 VS 2023 VS 2030
1.3.2 Infant Formula
1.3.3 Functional Food & Beverages
1.3.4 Food/Medical Supplements
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Goals and Objectives
2 HUMAN MILK OLIGOSACCHARIDES (HMO) MARKET DYNAMICS
2.1 Human Milk Oligosaccharides (HMO) Industry Trends
2.2 Human Milk Oligosaccharides (HMO) Industry Drivers
2.3 Human Milk Oligosaccharides (HMO) Industry Opportunities and Challenges
2.4 Human Milk Oligosaccharides (HMO) Industry Restraints
3 GLOBAL MARKET GROWTH PROSPECTS
3.1 Global Human Milk Oligosaccharides (HMO) Revenue Estimates and Forecasts (2019-2030)
3.2 Global Human Milk Oligosaccharides (HMO) Revenue by Region
3.2.1 Global Human Milk Oligosaccharides (HMO) Revenue by Region: 2019 VS 2023 VS 2030
3.2.2 Global Human Milk Oligosaccharides (HMO) Revenue by Region (2019-2024)
3.2.3 Global Human Milk Oligosaccharides (HMO) Revenue by Region (2025-2030)
3.2.4 Global Human Milk Oligosaccharides (HMO) Revenue Market Share by Region (2019-2030)
3.3 Global Human Milk Oligosaccharides (HMO) Sales Estimates and Forecasts 2019-2030
3.4 Global Human Milk Oligosaccharides (HMO) Sales by Region
3.4.1 Global Human Milk Oligosaccharides (HMO) Sales by Region: 2019 VS 2023 VS 2030
3.4.2 Global Human Milk Oligosaccharides (HMO) Sales by Region (2019-2024)
3.4.3 Global Human Milk Oligosaccharides (HMO) Sales by Region (2025-2030)
3.4.4 Global Human Milk Oligosaccharides (HMO) Sales Market Share by Region (2019-2030)
3.5 US & Canada
3.6 Europe
3.7 China
3.8 Asia (Excluding China)
3.9 Middle East, Africa and Latin America
4 MARKET COMPETITIVE LANDSCAPE BY MANUFACTURERS
4.1 Global Human Milk Oligosaccharides (HMO) Revenue by Manufacturers
4.1.1 Global Human Milk Oligosaccharides (HMO) Revenue by Manufacturers (2019-2024)
4.1.2 Global Human Milk Oligosaccharides (HMO) Revenue Market Share by Manufacturers (2019-2024)
4.1.3 Global Human Milk Oligosaccharides (HMO) Manufacturers Revenue Share Top 10 and Top 5 in 2023
4.2 Global Human Milk Oligosaccharides (HMO) Sales by Manufacturers
4.2.1 Global Human Milk Oligosaccharides (HMO) Sales by Manufacturers (2019-2024)
4.2.2 Global Human Milk Oligosaccharides (HMO) Sales Market Share by Manufacturers (2019-2024)
4.2.3 Global Human Milk Oligosaccharides (HMO) Manufacturers Sales Share Top 10 and Top 5 in 2023
4.3 Global Human Milk Oligosaccharides (HMO) Sales Price by Manufacturers (2019-2024)
4.4 Global Human Milk Oligosaccharides (HMO) Key Manufacturers Ranking, 2022 VS 2023 VS 2024
4.5 Global Human Milk Oligosaccharides (HMO) Key Manufacturers Manufacturing Sites & Headquarters
4.6 Global Human Milk Oligosaccharides (HMO) Manufacturers, Product Type & Application
4.7 Global Human Milk Oligosaccharides (HMO) Manufacturers Commercialization Time
4.8 Market Competitive Analysis
4.8.1 Global Human Milk Oligosaccharides (HMO) Market CR5 and HHI
4.8.2 2023 Human Milk Oligosaccharides (HMO) Tier 1, Tier 2, and Tier
5 HUMAN MILK OLIGOSACCHARIDES (HMO) MARKET BY TYPE
5.1 Global Human Milk Oligosaccharides (HMO) Revenue by Type
5.1.1 Global Human Milk Oligosaccharides (HMO) Revenue by Type (2019 VS 2023 VS 2030)
5.1.2 Global Human Milk Oligosaccharides (HMO) Revenue by Type (2019-2030) & (US$ Million)
5.1.3 Global Human Milk Oligosaccharides (HMO) Revenue Market Share by Type (2019-2030)
5.2 Global Human Milk Oligosaccharides (HMO) Sales by Type
5.2.1 Global Human Milk Oligosaccharides (HMO) Sales by Type (2019 VS 2023 VS 2030)
5.2.2 Global Human Milk Oligosaccharides (HMO) Sales by Type (2019-2030) & (Tons)
5.2.3 Global Human Milk Oligosaccharides (HMO) Sales Market Share by Type (2019-2030)
5.3 Global Human Milk Oligosaccharides (HMO) Price by Type
6 HUMAN MILK OLIGOSACCHARIDES (HMO) MARKET BY APPLICATION
6.1 Global Human Milk Oligosaccharides (HMO) Revenue by Application
6.1.1 Global Human Milk Oligosaccharides (HMO) Revenue by Application (2019 VS 2023 VS 2030)
6.1.2 Global Human Milk Oligosaccharides (HMO) Revenue by Application (2019-2030) & (US$ Million)
6.1.3 Global Human Milk Oligosaccharides (HMO) Revenue Market Share by Application (2019-2030)
6.2 Global Human Milk Oligosaccharides (HMO) Sales by Application
6.2.1 Global Human Milk Oligosaccharides (HMO) Sales by Application (2019 VS 2023 VS 2030)
6.2.2 Global Human Milk Oligosaccharides (HMO) Sales by Application (2019-2030) & (Tons)
6.2.3 Global Human Milk Oligosaccharides (HMO) Sales Market Share by Application (2019-2030)
6.3 Global Human Milk Oligosaccharides (HMO) Price by Application
7 COMPANY PROFILES
7.1 Abbott
7.1.1 Abbott Comapny Information
7.1.2 Abbott Business Overview
7.1.3 Abbott Human Milk Oligosaccharides (HMO) Sales, Revenue, Price and Gross Margin (2019-2024)
7.1.4 Abbott Human Milk Oligosaccharides (HMO) Product Portfolio
7.1.5 Abbott Recent Developments
7.2 Inbiose
7.2.1 Inbiose Comapny Information
7.2.2 Inbiose Business Overview
7.2.3 Inbiose Human Milk Oligosaccharides (HMO) Sales, Revenue, Price and Gross Margin (2019-2024)
7.2.4 Inbiose Human Milk Oligosaccharides (HMO) Product Portfolio
7.2.5 Inbiose Recent Developments
7.3 Glycom
7.3.1 Glycom Comapny Information
7.3.2 Glycom Business Overview
7.3.3 Glycom Human Milk Oligosaccharides (HMO) Sales, Revenue, Price and Gross Margin (2019-2024)
7.3.4 Glycom Human Milk Oligosaccharides (HMO) Product Portfolio
7.3.5 Glycom Recent Developments
7.4 Chr. Hansen (Jennewein)
7.4.1 Chr. Hansen (Jennewein) Comapny Information
7.4.2 Chr. Hansen (Jennewein) Business Overview
7.4.3 Chr. Hansen (Jennewein) Human Milk Oligosaccharides (HMO) Sales, Revenue, Price and Gross Margin (2019-2024)
7.4.4 Chr. Hansen (Jennewein) Human Milk Oligosaccharides (HMO) Product Portfolio
7.4.5 Chr. Hansen (Jennewein) Recent Developments
7.5 Elicityl SA
7.5.1 Elicityl SA Comapny Information
7.5.2 Elicityl SA Business Overview
7.5.3 Elicityl SA Human Milk Oligosaccharides (HMO) Sales, Revenue, Price and Gross Margin (2019-2024)
7.5.4 Elicityl SA Human Milk Oligosaccharides (HMO) Product Portfolio
7.5.5 Elicityl SA Recent Developments
7.6 ZuChem
7.6.1 ZuChem Comapny Information
7.6.2 ZuChem Business Overview
7.6.3 ZuChem Human Milk Oligosaccharides (HMO) Sales, Revenue, Price and Gross Margin (2019-2024)
7.6.4 ZuChem Human Milk Oligosaccharides (HMO) Product Portfolio
7.6.5 ZuChem Recent Developments
7.7 Dextra Laboratories
7.7.1 Dextra Laboratories Comapny Information
7.7.2 Dextra Laboratories Business Overview
7.7.3 Dextra Laboratories Human Milk Oligosaccharides (HMO) Sales, Revenue, Price and Gross Margin (2019-2024)
7.7.4 Dextra Laboratories Human Milk Oligosaccharides (HMO) Product Portfolio
7.7.5 Dextra Laboratories Recent Developments
8 NORTH AMERICA
8.1 North America Human Milk Oligosaccharides (HMO) Market Size by Type
8.1.1 North America Human Milk Oligosaccharides (HMO) Revenue by Type (2019-2030)
8.1.2 North America Human Milk Oligosaccharides (HMO) Sales by Type (2019-2030)
8.1.3 North America Human Milk Oligosaccharides (HMO) Price by Type (2019-2030)
8.2 North America Human Milk Oligosaccharides (HMO) Market Size by Application
8.2.1 North America Human Milk Oligosaccharides (HMO) Revenue by Application (2019-2030)
8.2.2 North America Human Milk Oligosaccharides (HMO) Sales by Application (2019-2030)
8.2.3 North America Human Milk Oligosaccharides (HMO) Price by Application (2019-2030)
8.3 North America Human Milk Oligosaccharides (HMO) Market Size by Country
8.3.1 North America Human Milk Oligosaccharides (HMO) Revenue Grow Rate by Country (2019 VS 2023 VS 2030)
8.3.2 North America Human Milk Oligosaccharides (HMO) Sales by Country (2019 VS 2023 VS 2030)
8.3.3 North America Human Milk Oligosaccharides (HMO) Price by Country (2019-2030)
8.3.4 U.S.
8.3.5 Canada
9 EUROPE
9.1 Europe Human Milk Oligosaccharides (HMO) Market Size by Type
9.1.1 Europe Human Milk Oligosaccharides (HMO) Revenue by Type (2019-2030)
9.1.2 Europe Human Milk Oligosaccharides (HMO) Sales by Type (2019-2030)
9.1.3 Europe Human Milk Oligosaccharides (HMO) Price by Type (2019-2030)
9.2 Europe Human Milk Oligosaccharides (HMO) Market Size by Application
9.2.1 Europe Human Milk Oligosaccharides (HMO) Revenue by Application (2019-2030)
9.2.2 Europe Human Milk Oligosaccharides (HMO) Sales by Application (2019-2030)
9.2.3 Europe Human Milk Oligosaccharides (HMO) Price by Application (2019-2030)
9.3 Europe Human Milk Oligosaccharides (HMO) Market Size by Country
9.3.1 Europe Human Milk Oligosaccharides (HMO) Revenue Grow Rate by Country (2019 VS 2023 VS 2030)
9.3.2 Europe Human Milk Oligosaccharides (HMO) Sales by Country (2019 VS 2023 VS 2030)
9.3.3 Europe Human Milk Oligosaccharides (HMO) Price by Country (2019-2030)
9.3.4 Germany
9.3.5 France
9.3.6 U.K.
9.3.7 Italy
9.3.8 Russia
10 CHINA
10.1 China Human Milk Oligosaccharides (HMO) Market Size by Type
10.1.1 China Human Milk Oligosaccharides (HMO) Revenue by Type (2019-2030)
10.1.2 China Human Milk Oligosaccharides (HMO) Sales by Type (2019-2030)
10.1.3 China Human Milk Oligosaccharides (HMO) Price by Type (2019-2030)
10.2 China Human Milk Oligosaccharides (HMO) Market Size by Application
10.2.1 China Human Milk Oligosaccharides (HMO) Revenue by Application (2019-2030)
10.2.2 China Human Milk Oligosaccharides (HMO) Sales by Application (2019-2030)
10.2.3 China Human Milk Oligosaccharides (HMO) Price by Application (2019-2030)
11 ASIA (EXCLUDING CHINA)
11.1 Asia Human Milk Oligosaccharides (HMO) Market Size by Type
11.1.1 Asia Human Milk Oligosaccharides (HMO) Revenue by Type (2019-2030)
11.1.2 Asia Human Milk Oligosaccharides (HMO) Sales by Type (2019-2030)
11.1.3 Asia Human Milk Oligosaccharides (HMO) Price by Type (2019-2030)
11.2 Asia Human Milk Oligosaccharides (HMO) Market Size by Application
11.2.1 Asia Human Milk Oligosaccharides (HMO) Revenue by Application (2019-2030)
11.2.2 Asia Human Milk Oligosaccharides (HMO) Sales by Application (2019-2030)
11.2.3 Asia Human Milk Oligosaccharides (HMO) Price by Application (2019-2030)
11.3 Asia Human Milk Oligosaccharides (HMO) Market Size by Country
11.3.1 Asia Human Milk Oligosaccharides (HMO) Revenue Grow Rate by Country (2019 VS 2023 VS 2030)
11.3.2 Asia Human Milk Oligosaccharides (HMO) Sales by Country (2019 VS 2023 VS 2030)
11.3.3 Asia Human Milk Oligosaccharides (HMO) Price by Country (2019-2030)
11.3.4 Japan
11.3.5 South Korea
11.3.6 India
11.3.7 Australia
11.3.8 China Taiwan
11.3.9 Southeast Asia
12 MIDDLE EAST, AFRICA AND LATIN AMERICA
12.1 MEALA Human Milk Oligosaccharides (HMO) Market Size by Type
12.1.1 MEALA Human Milk Oligosaccharides (HMO) Revenue by Type (2019-2030)
12.1.2 MEALA Human Milk Oligosaccharides (HMO) Sales by Type (2019-2030)
12.1.3 MEALA Human Milk Oligosaccharides (HMO) Price by Type (2019-2030)
12.2 MEALA Human Milk Oligosaccharides (HMO) Market Size by Application
12.2.1 MEALA Human Milk Oligosaccharides (HMO) Revenue by Application (2019-2030)
12.2.2 MEALA Human Milk Oligosaccharides (HMO) Sales by Application (2019-2030)
12.2.3 MEALA Human Milk Oligosaccharides (HMO) Price by Application (2019-2030)
12.3 MEALA Human Milk Oligosaccharides (HMO) Market Size by Country
12.3.1 MEALA Human Milk Oligosaccharides (HMO) Revenue Grow Rate by Country (2019 VS 2023 VS 2030)
12.3.2 MEALA Human Milk Oligosaccharides (HMO) Sales by Country (2019 VS 2023 VS 2030)
12.3.3 MEALA Human Milk Oligosaccharides (HMO) Price by Country (2019-2030)
12.3.4 Mexico
12.3.5 Brazil
12.3.6 Israel
12.3.7 Argentina
12.3.8 Colombia
12.3.9 Turkey
12.3.10 Saudi Arabia
12.3.11 UAE
13 VALUE CHAIN AND SALES CHANNELS ANALYSIS
13.1 Human Milk Oligosaccharides (HMO) Value Chain Analysis
13.1.1 Human Milk Oligosaccharides (HMO) Key Raw Materials
13.1.2 Raw Materials Key Suppliers
13.1.3 Manufacturing Cost Structure
13.1.4 Human Milk Oligosaccharides (HMO) Production Mode & Process
13.2 Human Milk Oligosaccharides (HMO) Sales Channels Analysis
13.2.1 Direct Comparison with Distribution Share
13.2.2 Human Milk Oligosaccharides (HMO) Distributors
13.2.3 Human Milk Oligosaccharides (HMO) Customers
14 CONCLUDING INSIGHTS
15 APPENDIX
15.1 Reasons for Doing This Study
15.2 Research Methodology
15.3 Research Process
15.4 Authors List of This Report
15.5 Data Source
15.5.1 Secondary Sources
15.5.2 Primary Sources
15.6 Disclaimer
1.1 Product Definition
1.2 Human Milk Oligosaccharides (HMO) Market by Type
1.2.1 Global Human Milk Oligosaccharides (HMO) Market Size by Type, 2019 VS 2023 VS 2030
1.2.2 2'-FL & 3-FL
1.2.3 Sialyllactose
1.2.4 LNT & LNnT
1.3 Human Milk Oligosaccharides (HMO) Market by Application
1.3.1 Global Human Milk Oligosaccharides (HMO) Market Size by Application, 2019 VS 2023 VS 2030
1.3.2 Infant Formula
1.3.3 Functional Food & Beverages
1.3.4 Food/Medical Supplements
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Goals and Objectives
2 HUMAN MILK OLIGOSACCHARIDES (HMO) MARKET DYNAMICS
2.1 Human Milk Oligosaccharides (HMO) Industry Trends
2.2 Human Milk Oligosaccharides (HMO) Industry Drivers
2.3 Human Milk Oligosaccharides (HMO) Industry Opportunities and Challenges
2.4 Human Milk Oligosaccharides (HMO) Industry Restraints
3 GLOBAL MARKET GROWTH PROSPECTS
3.1 Global Human Milk Oligosaccharides (HMO) Revenue Estimates and Forecasts (2019-2030)
3.2 Global Human Milk Oligosaccharides (HMO) Revenue by Region
3.2.1 Global Human Milk Oligosaccharides (HMO) Revenue by Region: 2019 VS 2023 VS 2030
3.2.2 Global Human Milk Oligosaccharides (HMO) Revenue by Region (2019-2024)
3.2.3 Global Human Milk Oligosaccharides (HMO) Revenue by Region (2025-2030)
3.2.4 Global Human Milk Oligosaccharides (HMO) Revenue Market Share by Region (2019-2030)
3.3 Global Human Milk Oligosaccharides (HMO) Sales Estimates and Forecasts 2019-2030
3.4 Global Human Milk Oligosaccharides (HMO) Sales by Region
3.4.1 Global Human Milk Oligosaccharides (HMO) Sales by Region: 2019 VS 2023 VS 2030
3.4.2 Global Human Milk Oligosaccharides (HMO) Sales by Region (2019-2024)
3.4.3 Global Human Milk Oligosaccharides (HMO) Sales by Region (2025-2030)
3.4.4 Global Human Milk Oligosaccharides (HMO) Sales Market Share by Region (2019-2030)
3.5 US & Canada
3.6 Europe
3.7 China
3.8 Asia (Excluding China)
3.9 Middle East, Africa and Latin America
4 MARKET COMPETITIVE LANDSCAPE BY MANUFACTURERS
4.1 Global Human Milk Oligosaccharides (HMO) Revenue by Manufacturers
4.1.1 Global Human Milk Oligosaccharides (HMO) Revenue by Manufacturers (2019-2024)
4.1.2 Global Human Milk Oligosaccharides (HMO) Revenue Market Share by Manufacturers (2019-2024)
4.1.3 Global Human Milk Oligosaccharides (HMO) Manufacturers Revenue Share Top 10 and Top 5 in 2023
4.2 Global Human Milk Oligosaccharides (HMO) Sales by Manufacturers
4.2.1 Global Human Milk Oligosaccharides (HMO) Sales by Manufacturers (2019-2024)
4.2.2 Global Human Milk Oligosaccharides (HMO) Sales Market Share by Manufacturers (2019-2024)
4.2.3 Global Human Milk Oligosaccharides (HMO) Manufacturers Sales Share Top 10 and Top 5 in 2023
4.3 Global Human Milk Oligosaccharides (HMO) Sales Price by Manufacturers (2019-2024)
4.4 Global Human Milk Oligosaccharides (HMO) Key Manufacturers Ranking, 2022 VS 2023 VS 2024
4.5 Global Human Milk Oligosaccharides (HMO) Key Manufacturers Manufacturing Sites & Headquarters
4.6 Global Human Milk Oligosaccharides (HMO) Manufacturers, Product Type & Application
4.7 Global Human Milk Oligosaccharides (HMO) Manufacturers Commercialization Time
4.8 Market Competitive Analysis
4.8.1 Global Human Milk Oligosaccharides (HMO) Market CR5 and HHI
4.8.2 2023 Human Milk Oligosaccharides (HMO) Tier 1, Tier 2, and Tier
5 HUMAN MILK OLIGOSACCHARIDES (HMO) MARKET BY TYPE
5.1 Global Human Milk Oligosaccharides (HMO) Revenue by Type
5.1.1 Global Human Milk Oligosaccharides (HMO) Revenue by Type (2019 VS 2023 VS 2030)
5.1.2 Global Human Milk Oligosaccharides (HMO) Revenue by Type (2019-2030) & (US$ Million)
5.1.3 Global Human Milk Oligosaccharides (HMO) Revenue Market Share by Type (2019-2030)
5.2 Global Human Milk Oligosaccharides (HMO) Sales by Type
5.2.1 Global Human Milk Oligosaccharides (HMO) Sales by Type (2019 VS 2023 VS 2030)
5.2.2 Global Human Milk Oligosaccharides (HMO) Sales by Type (2019-2030) & (Tons)
5.2.3 Global Human Milk Oligosaccharides (HMO) Sales Market Share by Type (2019-2030)
5.3 Global Human Milk Oligosaccharides (HMO) Price by Type
6 HUMAN MILK OLIGOSACCHARIDES (HMO) MARKET BY APPLICATION
6.1 Global Human Milk Oligosaccharides (HMO) Revenue by Application
6.1.1 Global Human Milk Oligosaccharides (HMO) Revenue by Application (2019 VS 2023 VS 2030)
6.1.2 Global Human Milk Oligosaccharides (HMO) Revenue by Application (2019-2030) & (US$ Million)
6.1.3 Global Human Milk Oligosaccharides (HMO) Revenue Market Share by Application (2019-2030)
6.2 Global Human Milk Oligosaccharides (HMO) Sales by Application
6.2.1 Global Human Milk Oligosaccharides (HMO) Sales by Application (2019 VS 2023 VS 2030)
6.2.2 Global Human Milk Oligosaccharides (HMO) Sales by Application (2019-2030) & (Tons)
6.2.3 Global Human Milk Oligosaccharides (HMO) Sales Market Share by Application (2019-2030)
6.3 Global Human Milk Oligosaccharides (HMO) Price by Application
7 COMPANY PROFILES
7.1 Abbott
7.1.1 Abbott Comapny Information
7.1.2 Abbott Business Overview
7.1.3 Abbott Human Milk Oligosaccharides (HMO) Sales, Revenue, Price and Gross Margin (2019-2024)
7.1.4 Abbott Human Milk Oligosaccharides (HMO) Product Portfolio
7.1.5 Abbott Recent Developments
7.2 Inbiose
7.2.1 Inbiose Comapny Information
7.2.2 Inbiose Business Overview
7.2.3 Inbiose Human Milk Oligosaccharides (HMO) Sales, Revenue, Price and Gross Margin (2019-2024)
7.2.4 Inbiose Human Milk Oligosaccharides (HMO) Product Portfolio
7.2.5 Inbiose Recent Developments
7.3 Glycom
7.3.1 Glycom Comapny Information
7.3.2 Glycom Business Overview
7.3.3 Glycom Human Milk Oligosaccharides (HMO) Sales, Revenue, Price and Gross Margin (2019-2024)
7.3.4 Glycom Human Milk Oligosaccharides (HMO) Product Portfolio
7.3.5 Glycom Recent Developments
7.4 Chr. Hansen (Jennewein)
7.4.1 Chr. Hansen (Jennewein) Comapny Information
7.4.2 Chr. Hansen (Jennewein) Business Overview
7.4.3 Chr. Hansen (Jennewein) Human Milk Oligosaccharides (HMO) Sales, Revenue, Price and Gross Margin (2019-2024)
7.4.4 Chr. Hansen (Jennewein) Human Milk Oligosaccharides (HMO) Product Portfolio
7.4.5 Chr. Hansen (Jennewein) Recent Developments
7.5 Elicityl SA
7.5.1 Elicityl SA Comapny Information
7.5.2 Elicityl SA Business Overview
7.5.3 Elicityl SA Human Milk Oligosaccharides (HMO) Sales, Revenue, Price and Gross Margin (2019-2024)
7.5.4 Elicityl SA Human Milk Oligosaccharides (HMO) Product Portfolio
7.5.5 Elicityl SA Recent Developments
7.6 ZuChem
7.6.1 ZuChem Comapny Information
7.6.2 ZuChem Business Overview
7.6.3 ZuChem Human Milk Oligosaccharides (HMO) Sales, Revenue, Price and Gross Margin (2019-2024)
7.6.4 ZuChem Human Milk Oligosaccharides (HMO) Product Portfolio
7.6.5 ZuChem Recent Developments
7.7 Dextra Laboratories
7.7.1 Dextra Laboratories Comapny Information
7.7.2 Dextra Laboratories Business Overview
7.7.3 Dextra Laboratories Human Milk Oligosaccharides (HMO) Sales, Revenue, Price and Gross Margin (2019-2024)
7.7.4 Dextra Laboratories Human Milk Oligosaccharides (HMO) Product Portfolio
7.7.5 Dextra Laboratories Recent Developments
8 NORTH AMERICA
8.1 North America Human Milk Oligosaccharides (HMO) Market Size by Type
8.1.1 North America Human Milk Oligosaccharides (HMO) Revenue by Type (2019-2030)
8.1.2 North America Human Milk Oligosaccharides (HMO) Sales by Type (2019-2030)
8.1.3 North America Human Milk Oligosaccharides (HMO) Price by Type (2019-2030)
8.2 North America Human Milk Oligosaccharides (HMO) Market Size by Application
8.2.1 North America Human Milk Oligosaccharides (HMO) Revenue by Application (2019-2030)
8.2.2 North America Human Milk Oligosaccharides (HMO) Sales by Application (2019-2030)
8.2.3 North America Human Milk Oligosaccharides (HMO) Price by Application (2019-2030)
8.3 North America Human Milk Oligosaccharides (HMO) Market Size by Country
8.3.1 North America Human Milk Oligosaccharides (HMO) Revenue Grow Rate by Country (2019 VS 2023 VS 2030)
8.3.2 North America Human Milk Oligosaccharides (HMO) Sales by Country (2019 VS 2023 VS 2030)
8.3.3 North America Human Milk Oligosaccharides (HMO) Price by Country (2019-2030)
8.3.4 U.S.
8.3.5 Canada
9 EUROPE
9.1 Europe Human Milk Oligosaccharides (HMO) Market Size by Type
9.1.1 Europe Human Milk Oligosaccharides (HMO) Revenue by Type (2019-2030)
9.1.2 Europe Human Milk Oligosaccharides (HMO) Sales by Type (2019-2030)
9.1.3 Europe Human Milk Oligosaccharides (HMO) Price by Type (2019-2030)
9.2 Europe Human Milk Oligosaccharides (HMO) Market Size by Application
9.2.1 Europe Human Milk Oligosaccharides (HMO) Revenue by Application (2019-2030)
9.2.2 Europe Human Milk Oligosaccharides (HMO) Sales by Application (2019-2030)
9.2.3 Europe Human Milk Oligosaccharides (HMO) Price by Application (2019-2030)
9.3 Europe Human Milk Oligosaccharides (HMO) Market Size by Country
9.3.1 Europe Human Milk Oligosaccharides (HMO) Revenue Grow Rate by Country (2019 VS 2023 VS 2030)
9.3.2 Europe Human Milk Oligosaccharides (HMO) Sales by Country (2019 VS 2023 VS 2030)
9.3.3 Europe Human Milk Oligosaccharides (HMO) Price by Country (2019-2030)
9.3.4 Germany
9.3.5 France
9.3.6 U.K.
9.3.7 Italy
9.3.8 Russia
10 CHINA
10.1 China Human Milk Oligosaccharides (HMO) Market Size by Type
10.1.1 China Human Milk Oligosaccharides (HMO) Revenue by Type (2019-2030)
10.1.2 China Human Milk Oligosaccharides (HMO) Sales by Type (2019-2030)
10.1.3 China Human Milk Oligosaccharides (HMO) Price by Type (2019-2030)
10.2 China Human Milk Oligosaccharides (HMO) Market Size by Application
10.2.1 China Human Milk Oligosaccharides (HMO) Revenue by Application (2019-2030)
10.2.2 China Human Milk Oligosaccharides (HMO) Sales by Application (2019-2030)
10.2.3 China Human Milk Oligosaccharides (HMO) Price by Application (2019-2030)
11 ASIA (EXCLUDING CHINA)
11.1 Asia Human Milk Oligosaccharides (HMO) Market Size by Type
11.1.1 Asia Human Milk Oligosaccharides (HMO) Revenue by Type (2019-2030)
11.1.2 Asia Human Milk Oligosaccharides (HMO) Sales by Type (2019-2030)
11.1.3 Asia Human Milk Oligosaccharides (HMO) Price by Type (2019-2030)
11.2 Asia Human Milk Oligosaccharides (HMO) Market Size by Application
11.2.1 Asia Human Milk Oligosaccharides (HMO) Revenue by Application (2019-2030)
11.2.2 Asia Human Milk Oligosaccharides (HMO) Sales by Application (2019-2030)
11.2.3 Asia Human Milk Oligosaccharides (HMO) Price by Application (2019-2030)
11.3 Asia Human Milk Oligosaccharides (HMO) Market Size by Country
11.3.1 Asia Human Milk Oligosaccharides (HMO) Revenue Grow Rate by Country (2019 VS 2023 VS 2030)
11.3.2 Asia Human Milk Oligosaccharides (HMO) Sales by Country (2019 VS 2023 VS 2030)
11.3.3 Asia Human Milk Oligosaccharides (HMO) Price by Country (2019-2030)
11.3.4 Japan
11.3.5 South Korea
11.3.6 India
11.3.7 Australia
11.3.8 China Taiwan
11.3.9 Southeast Asia
12 MIDDLE EAST, AFRICA AND LATIN AMERICA
12.1 MEALA Human Milk Oligosaccharides (HMO) Market Size by Type
12.1.1 MEALA Human Milk Oligosaccharides (HMO) Revenue by Type (2019-2030)
12.1.2 MEALA Human Milk Oligosaccharides (HMO) Sales by Type (2019-2030)
12.1.3 MEALA Human Milk Oligosaccharides (HMO) Price by Type (2019-2030)
12.2 MEALA Human Milk Oligosaccharides (HMO) Market Size by Application
12.2.1 MEALA Human Milk Oligosaccharides (HMO) Revenue by Application (2019-2030)
12.2.2 MEALA Human Milk Oligosaccharides (HMO) Sales by Application (2019-2030)
12.2.3 MEALA Human Milk Oligosaccharides (HMO) Price by Application (2019-2030)
12.3 MEALA Human Milk Oligosaccharides (HMO) Market Size by Country
12.3.1 MEALA Human Milk Oligosaccharides (HMO) Revenue Grow Rate by Country (2019 VS 2023 VS 2030)
12.3.2 MEALA Human Milk Oligosaccharides (HMO) Sales by Country (2019 VS 2023 VS 2030)
12.3.3 MEALA Human Milk Oligosaccharides (HMO) Price by Country (2019-2030)
12.3.4 Mexico
12.3.5 Brazil
12.3.6 Israel
12.3.7 Argentina
12.3.8 Colombia
12.3.9 Turkey
12.3.10 Saudi Arabia
12.3.11 UAE
13 VALUE CHAIN AND SALES CHANNELS ANALYSIS
13.1 Human Milk Oligosaccharides (HMO) Value Chain Analysis
13.1.1 Human Milk Oligosaccharides (HMO) Key Raw Materials
13.1.2 Raw Materials Key Suppliers
13.1.3 Manufacturing Cost Structure
13.1.4 Human Milk Oligosaccharides (HMO) Production Mode & Process
13.2 Human Milk Oligosaccharides (HMO) Sales Channels Analysis
13.2.1 Direct Comparison with Distribution Share
13.2.2 Human Milk Oligosaccharides (HMO) Distributors
13.2.3 Human Milk Oligosaccharides (HMO) Customers
14 CONCLUDING INSIGHTS
15 APPENDIX
15.1 Reasons for Doing This Study
15.2 Research Methodology
15.3 Research Process
15.4 Authors List of This Report
15.5 Data Source
15.5.1 Secondary Sources
15.5.2 Primary Sources
15.6 Disclaimer
LIST OF TABLES
Table 1. Global Human Milk Oligosaccharides (HMO) Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
Table 2. 2'-FL & 3-FL Major Manufacturers
Table 3. Sialyllactose Major Manufacturers
Table 4. LNT & LNnT Major Manufacturers
Table 5. Global Human Milk Oligosaccharides (HMO) Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
Table 6. Infant Formula Major Manufacturers
Table 7. Functional Food & Beverages Major Manufacturers
Table 8. Food/Medical Supplements Major Manufacturers
Table 9. Others Major Manufacturers
Table 10. Human Milk Oligosaccharides (HMO) Industry Trends
Table 11. Human Milk Oligosaccharides (HMO) Industry Drivers
Table 12. Human Milk Oligosaccharides (HMO) Industry Opportunities and Challenges
Table 13. Human Milk Oligosaccharides (HMO) Industry Restraints
Table 14. Global Human Milk Oligosaccharides (HMO) Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 15. Global Human Milk Oligosaccharides (HMO) Revenue by Region (2019-2024) & (US$ Million)
Table 16. Global Human Milk Oligosaccharides (HMO) Revenue by Region (2025-2030) & (US$ Million)
Table 17. Global Human Milk Oligosaccharides (HMO) Revenue Market Share by Region (2019-2024)
Table 18. Global Human Milk Oligosaccharides (HMO) Revenue Market Share by Region (2025-2030)
Table 19. Global Human Milk Oligosaccharides (HMO) Sales Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (Tons)
Table 20. Global Human Milk Oligosaccharides (HMO) Sales by Region (2019-2024) & (Tons)
Table 21. Global Human Milk Oligosaccharides (HMO) Sales by Region (2025-2030) & (Tons)
Table 22. Global Human Milk Oligosaccharides (HMO) Sales Market Share by Region (2019-2024)
Table 23. Global Human Milk Oligosaccharides (HMO) Sales Market Share by Region (2025-2030)
Table 24. Global Human Milk Oligosaccharides (HMO) Revenue by Manufacturers (US$ Million) & (2019-2024)
Table 25. Global Human Milk Oligosaccharides (HMO) Revenue Market Share by Manufacturers (2019-2024)
Table 26. Global Human Milk Oligosaccharides (HMO) Sales by Manufacturers (US$ Million) & (2019-2024)
Table 27. Global Human Milk Oligosaccharides (HMO) Sales Market Share by Manufacturers (2019-2024)
Table 28. Global Human Milk Oligosaccharides (HMO) Sales Price (USD/Ton) of Manufacturers (2019-2024)
Table 29. Global Human Milk Oligosaccharides (HMO) Key Manufacturers Ranking, 2022 VS 2023 VS 2024
Table 30. Global Human Milk Oligosaccharides (HMO) Key Manufacturers Manufacturing Sites & Headquarters
Table 31. Global Human Milk Oligosaccharides (HMO) Manufacturers, Product Type & Application
Table 32. Global Human Milk Oligosaccharides (HMO) Manufacturers Commercialization Time
Table 33. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 34. Global Human Milk Oligosaccharides (HMO) by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2023)
Table 35. Global Human Milk Oligosaccharides (HMO) Revenue by Type 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Global Human Milk Oligosaccharides (HMO) Revenue by Type (2019-2024) & (US$ Million)
Table 37. Global Human Milk Oligosaccharides (HMO) Revenue by Type (2025-2030) & (US$ Million)
Table 38. Global Human Milk Oligosaccharides (HMO) Revenue Market Share by Type (2019-2024)
Table 39. Global Human Milk Oligosaccharides (HMO) Revenue Market Share by Type (2025-2030)
Table 40. Global Human Milk Oligosaccharides (HMO) Sales by Type 2019 VS 2023 VS 2030 (Tons)
Table 41. Global Human Milk Oligosaccharides (HMO) Sales by Type (2019-2024) & (Tons)
Table 42. Global Human Milk Oligosaccharides (HMO) Sales by Type (2025-2030) & (Tons)
Table 43. Global Human Milk Oligosaccharides (HMO) Sales Market Share by Type (2019-2024)
Table 44. Global Human Milk Oligosaccharides (HMO) Sales Market Share by Type (2025-2030)
Table 45. Global Human Milk Oligosaccharides (HMO) Price by Type (2019-2024) & (USD/Ton)
Table 46. Global Human Milk Oligosaccharides (HMO) Price by Type (2025-2030) & (USD/Ton)
Table 47. Global Human Milk Oligosaccharides (HMO) Revenue by Application 2019 VS 2023 VS 2030 (US$ Million)
Table 48. Global Human Milk Oligosaccharides (HMO) Revenue by Application (2019-2024) & (US$ Million)
Table 49. Global Human Milk Oligosaccharides (HMO) Revenue by Application (2025-2030) & (US$ Million)
Table 50. Global Human Milk Oligosaccharides (HMO) Revenue Market Share by Application (2019-2024)
Table 51. Global Human Milk Oligosaccharides (HMO) Revenue Market Share by Application (2025-2030)
Table 52. Global Human Milk Oligosaccharides (HMO) Sales by Application 2019 VS 2023 VS 2030 (Tons)
Table 53. Global Human Milk Oligosaccharides (HMO) Sales by Application (2019-2024) & (Tons)
Table 54. Global Human Milk Oligosaccharides (HMO) Sales by Application (2025-2030) & (Tons)
Table 55. Global Human Milk Oligosaccharides (HMO) Sales Market Share by Application (2019-2024)
Table 56. Global Human Milk Oligosaccharides (HMO) Sales Market Share by Application (2025-2030)
Table 57. Global Human Milk Oligosaccharides (HMO) Price by Application (2019-2024) & (USD/Ton)
Table 58. Global Human Milk Oligosaccharides (HMO) Price by Application (2025-2030) & (USD/Ton)
Table 59. Abbott Company Information
Table 60. Abbott Business Overview
Table 61. Abbott Human Milk Oligosaccharides (HMO) Sales (Tons), Revenue (US$ Million), Price (USD/Ton) and Gross Margin (2019-2024)
Table 62. Abbott Human Milk Oligosaccharides (HMO) Product Portfolio
Table 63. Abbott Recent Development
Table 64. Inbiose Company Information
Table 65. Inbiose Business Overview
Table 66. Inbiose Human Milk Oligosaccharides (HMO) Sales (Tons), Revenue (US$ Million), Price (USD/Ton) and Gross Margin (2019-2024)
Table 67. Inbiose Human Milk Oligosaccharides (HMO) Product Portfolio
Table 68. Inbiose Recent Development
Table 69. Glycom Company Information
Table 70. Glycom Business Overview
Table 71. Glycom Human Milk Oligosaccharides (HMO) Sales (Tons), Revenue (US$ Million), Price (USD/Ton) and Gross Margin (2019-2024)
Table 72. Glycom Human Milk Oligosaccharides (HMO) Product Portfolio
Table 73. Glycom Recent Development
Table 74. Chr. Hansen (Jennewein) Company Information
Table 75. Chr. Hansen (Jennewein) Business Overview
Table 76. Chr. Hansen (Jennewein) Human Milk Oligosaccharides (HMO) Sales (Tons), Revenue (US$ Million), Price (USD/Ton) and Gross Margin (2019-2024)
Table 77. Chr. Hansen (Jennewein) Human Milk Oligosaccharides (HMO) Product Portfolio
Table 78. Chr. Hansen (Jennewein) Recent Development
Table 79. Elicityl SA Company Information
Table 80. Elicityl SA Business Overview
Table 81. Elicityl SA Human Milk Oligosaccharides (HMO) Sales (Tons), Revenue (US$ Million), Price (USD/Ton) and Gross Margin (2019-2024)
Table 82. Elicityl SA Human Milk Oligosaccharides (HMO) Product Portfolio
Table 83. Elicityl SA Recent Development
Table 84. ZuChem Company Information
Table 85. ZuChem Business Overview
Table 86. ZuChem Human Milk Oligosaccharides (HMO) Sales (Tons), Revenue (US$ Million), Price (USD/Ton) and Gross Margin (2019-2024)
Table 87. ZuChem Human Milk Oligosaccharides (HMO) Product Portfolio
Table 88. ZuChem Recent Development
Table 89. Dextra Laboratories Company Information
Table 90. Dextra Laboratories Business Overview
Table 91. Dextra Laboratories Human Milk Oligosaccharides (HMO) Sales (Tons), Revenue (US$ Million), Price (USD/Ton) and Gross Margin (2019-2024)
Table 92. Dextra Laboratories Human Milk Oligosaccharides (HMO) Product Portfolio
Table 93. Dextra Laboratories Recent Development
Table 94. North America Human Milk Oligosaccharides (HMO) Revenue by Type (2019-2024) & (US$ Million)
Table 95. North America Human Milk Oligosaccharides (HMO) Revenue by Type (2025-2030) & (US$ Million)
Table 96. North America Human Milk Oligosaccharides (HMO) Sales by Type (2019-2024) & (Tons)
Table 97. North America Human Milk Oligosaccharides (HMO) Sales by Type (2025-2030) & (Tons)
Table 98. North America Human Milk Oligosaccharides (HMO) Sales Price by Type (2019-2024) & (USD/Ton)
Table 99. North America Human Milk Oligosaccharides (HMO) Sales Price by Type (2025-2030) & (USD/Ton)
Table 100. North America Human Milk Oligosaccharides (HMO) Revenue by Application (2019-2024) & (US$ Million)
Table 101. North America Human Milk Oligosaccharides (HMO) Revenue by Application (2025-2030) & (US$ Million)
Table 102. North America Human Milk Oligosaccharides (HMO) Sales by Application (2019-2024) & (Tons)
Table 103. North America Human Milk Oligosaccharides (HMO) Sales by Application (2025-2030) & (Tons)
Table 104. North America Human Milk Oligosaccharides (HMO) Sales Price by Application (2019-2024) & (USD/Ton)
Table 105. North America Human Milk Oligosaccharides (HMO) Sales Price by Application (2025-2030) & (USD/Ton)
Table 106. North America Human Milk Oligosaccharides (HMO) Revenue Grow Rate by Country (2019 VS 2023 VS 2030) & (US$ Million)
Table 107. North America Human Milk Oligosaccharides (HMO) Revenue Grow Rate by Country (2019-2024) & (US$ Million)
Table 108. North America Human Milk Oligosaccharides (HMO) Revenue Grow Rate by Country (2025-2030) & (US$ Million)
Table 109. North America Human Milk Oligosaccharides (HMO) Sales by Country (2019 VS 2023 VS 2030) & (Tons)
Table 110. North America Human Milk Oligosaccharides (HMO) Sales by Country (2019-2024) & (Tons)
Table 111. North America Human Milk Oligosaccharides (HMO) Sales by Country (2025-2030) & (Tons)
Table 112. North America Human Milk Oligosaccharides (HMO) Sales Price by Country (2019-2024) & (USD/Ton)
Table 113. North America Human Milk Oligosaccharides (HMO) Sales Price by Country (2025-2030) & (USD/Ton)
Table 114. US Human Milk Oligosaccharides (HMO) Revenue (2019-2030) & (US$ Million)
Table 115. Canada Human Milk Oligosaccharides (HMO) Revenue (2019-2030) & (US$ Million)
Table 116. Europe Human Milk Oligosaccharides (HMO) Revenue by Type (2019-2024) & (US$ Million)
Table 117. Europe Human Milk Oligosaccharides (HMO) Revenue by Type (2025-2030) & (US$ Million)
Table 118. Europe Human Milk Oligosaccharides (HMO) Sales by Type (2019-2024) & (Tons)
Table 119. Europe Human Milk Oligosaccharides (HMO) Sales by Type (2025-2030) & (Tons)
Table 120. Europe Human Milk Oligosaccharides (HMO) Sales Price by Type (2019-2024) & (USD/Ton)
Table 121. Europe Human Milk Oligosaccharides (HMO) Sales Price by Type (2025-2030) & (USD/Ton)
Table 122. Europe Human Milk Oligosaccharides (HMO) Revenue by Application (2019-2024) & (US$ Million)
Table 123. Europe Human Milk Oligosaccharides (HMO) Revenue by Application (2025-2030) & (US$ Million)
Table 124. Europe Human Milk Oligosaccharides (HMO) Sales by Application (2019-2024) & (Tons)
Table 125. Europe Human Milk Oligosaccharides (HMO) Sales by Application (2025-2030) & (Tons)
Table 126. Europe Human Milk Oligosaccharides (HMO) Sales Price by Application (2019-2024) & (USD/Ton)
Table 127. Europe Human Milk Oligosaccharides (HMO) Sales Price by Application (2025-2030) & (USD/Ton)
Table 128. Europe Human Milk Oligosaccharides (HMO) Revenue Grow Rate by Country (2019 VS 2023 VS 2030) & (US$ Million)
Table 129. Europe Human Milk Oligosaccharides (HMO) Revenue Grow Rate by Country (2019-2024) & (US$ Million)
Table 130. Europe Human Milk Oligosaccharides (HMO) Revenue Grow Rate by Country (2025-2030) & (US$ Million)
Table 131. Europe Human Milk Oligosaccharides (HMO) Sales by Country (2019 VS 2023 VS 2030) & (Tons)
Table 132. Europe Human Milk Oligosaccharides (HMO) Sales by Country (2019-2024) & (Tons)
Table 133. Europe Human Milk Oligosaccharides (HMO) Sales by Country (2025-2030) & (Tons)
Table 134. Europe Human Milk Oligosaccharides (HMO) Sales Price by Country (2019-2024) & (USD/Ton)
Table 135. Europe Human Milk Oligosaccharides (HMO) Sales Price by Country (2025-2030) & (USD/Ton)
Table 136. Germany Human Milk Oligosaccharides (HMO) Revenue (2019-2030) & (US$ Million)
Table 137. France Human Milk Oligosaccharides (HMO) Revenue (2019-2030) & (US$ Million)
Table 138. Human Milk Oligosaccharides (HMO) Revenue (2019-2030) & (US$ Million)
Table 139. Human Milk Oligosaccharides (HMO) Revenue (2019-2030) & (US$ Million)
Table 140. Human Milk Oligosaccharides (HMO) Revenue (2019-2030) & (US$ Million)
Table 141. China Human Milk Oligosaccharides (HMO) Revenue by Type (2019-2024) & (US$ Million)
Table 142. China Human Milk Oligosaccharides (HMO) Revenue by Type (2025-2030) & (US$ Million)
Table 143. China Human Milk Oligosaccharides (HMO) Sales by Type (2019-2024) & (Tons)
Table 144. China Human Milk Oligosaccharides (HMO) Sales by Type (2025-2030) & (Tons)
Table 145. China Human Milk Oligosaccharides (HMO) Sales Price by Type (2019-2024) & (USD/Ton)
Table 146. China Human Milk Oligosaccharides (HMO) Sales Price by Type (2025-2030) & (USD/Ton)
Table 147. China Human Milk Oligosaccharides (HMO) Revenue by Application (2019-2024) & (US$ Million)
Table 148. China Human Milk Oligosaccharides (HMO) Revenue by Application (2025-2030) & (US$ Million)
Table 149. China Human Milk Oligosaccharides (HMO) Sales by Application (2019-2024) & (Tons)
Table 150. China Human Milk Oligosaccharides (HMO) Sales by Application (2025-2030) & (Tons)
Table 151. China Human Milk Oligosaccharides (HMO) Sales Price by Application (2019-2024) & (USD/Ton)
Table 152. China Human Milk Oligosaccharides (HMO) Sales Price by Application (2025-2030) & (USD/Ton)
Table 153. Asia Human Milk Oligosaccharides (HMO) Revenue by Type (2019-2024) & (US$ Million)
Table 154. Asia Human Milk Oligosaccharides (HMO) Revenue by Type (2025-2030) & (US$ Million)
Table 155. Asia Human Milk Oligosaccharides (HMO) Sales by Type (2019-2024) & (Tons)
Table 156. Asia Human Milk Oligosaccharides (HMO) Sales by Type (2025-2030) & (Tons)
Table 157. Asia Human Milk Oligosaccharides (HMO) Sales Price by Type (2019-2024) & (USD/Ton)
Table 158. Asia Human Milk Oligosaccharides (HMO) Sales Price by Type (2025-2030) & (USD/Ton)
Table 159. Asia Human Milk Oligosaccharides (HMO) Revenue by Application (2019-2024) & (US$ Million)
Table 160. Asia Human Milk Oligosaccharides (HMO) Revenue by Application (2025-2030) & (US$ Million)
Table 161. Asia Human Milk Oligosaccharides (HMO) Sales by Application (2019-2024) & (Tons)
Table 162. Asia Human Milk Oligosaccharides (HMO) Sales by Application (2025-2030) & (Tons)
Table 163. Asia Human Milk Oligosaccharides (HMO) Sales Price by Application (2019-2024) & (USD/Ton)
Table 164. Asia Human Milk Oligosaccharides (HMO) Sales Price by Application (2025-2030) & (USD/Ton)
Table 165. Asia Human Milk Oligosaccharides (HMO) Revenue Grow Rate by Country (2019 VS 2023 VS 2030) & (US$ Million)
Table 166. Asia Human Milk Oligosaccharides (HMO) Revenue Grow Rate by Country (2019-2024) & (US$ Million)
Table 167. Asia Human Milk Oligosaccharides (HMO) Revenue Grow Rate by Country (2025-2030) & (US$ Million)
Table 168. Asia Human Milk Oligosaccharides (HMO) Sales by Country (2019 VS 2023 VS 2030) & (Tons)
Table 169. Asia Human Milk Oligosaccharides (HMO) Sales by Country (2019-2024) & (Tons)
Table 170. Asia Human Milk Oligosaccharides (HMO) Sales by Country (2025-2030) & (Tons)
Table 171. Asia Human Milk Oligosaccharides (HMO) Sales Price by Country (2019-2024) & (USD/Ton)
Table 172. Asia Human Milk Oligosaccharides (HMO) Sales Price by Country (2025-2030) & (USD/Ton)
Table 173. Japan Human Milk Oligosaccharides (HMO) Revenue (2019-2030) & (US$ Million)
Table 174. South Korea Human Milk Oligosaccharides (HMO) Revenue (2019-2030) & (US$ Million)
Table 175. Human Milk Oligosaccharides (HMO) Revenue (2019-2030) & (US$ Million)
Table 176. Human Milk Oligosaccharides (HMO) Revenue (2019-2030) & (US$ Million)
Table 177. Human Milk Oligosaccharides (HMO) Revenue (2019-2030) & (US$ Million)
Table 178. Human Milk Oligosaccharides (HMO) Revenue (2019-2030) & (US$ Million)
Table 179. Human Milk Oligosaccharides (HMO) Revenue (2019-2030) & (US$ Million)
Table 180. Human Milk Oligosaccharides (HMO) Revenue (2019-2030) & (US$ Million)
Table 181. MEALA Human Milk Oligosaccharides (HMO) Revenue by Type (2019-2024) & (US$ Million)
Table 182. MEALA Human Milk Oligosaccharides (HMO) Revenue by Type (2025-2030) & (US$ Million)
Table 183. MEALA Human Milk Oligosaccharides (HMO) Sales by Type (2019-2024) & (Tons)
Table 184. MEALA Human Milk Oligosaccharides (HMO) Sales by Type (2025-2030) & (Tons)
Table 185. MEALA Human Milk Oligosaccharides (HMO) Sales Price by Type (2019-2024) & (USD/Ton)
Table 186. MEALA Human Milk Oligosaccharides (HMO) Sales Price by Type (2025-2030) & (USD/Ton)
Table 187. MEALA Human Milk Oligosaccharides (HMO) Revenue by Application (2019-2024) & (US$ Million)
Table 188. MEALA Human Milk Oligosaccharides (HMO) Revenue by Application (2025-2030) & (US$ Million)
Table 189. MEALA Human Milk Oligosaccharides (HMO) Sales by Application (2019-2024) & (Tons)
Table 190. MEALA Human Milk Oligosaccharides (HMO) Sales by Application (2025-2030) & (Tons)
Table 191. MEALA Human Milk Oligosaccharides (HMO) Sales Price by Application (2019-2024) & (USD/Ton)
Table 192. MEALA Human Milk Oligosaccharides (HMO) Sales Price by Application (2025-2030) & (USD/Ton)
Table 193. MEALA Human Milk Oligosaccharides (HMO) Revenue Grow Rate by Country (2019 VS 2023 VS 2030) & (US$ Million)
Table 194. MEALA Human Milk Oligosaccharides (HMO) Revenue Grow Rate by Country (2019-2024) & (US$ Million)
Table 195. MEALA Human Milk Oligosaccharides (HMO) Revenue Grow Rate by Country (2025-2030) & (US$ Million)
Table 196. MEALA Human Milk Oligosaccharides (HMO) Sales by Country (2019 VS 2023 VS 2030) & (Tons)
Table 197. MEALA Human Milk Oligosaccharides (HMO) Sales by Country (2019-2024) & (Tons)
Table 198. MEALA Human Milk Oli
Table 1. Global Human Milk Oligosaccharides (HMO) Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
Table 2. 2'-FL & 3-FL Major Manufacturers
Table 3. Sialyllactose Major Manufacturers
Table 4. LNT & LNnT Major Manufacturers
Table 5. Global Human Milk Oligosaccharides (HMO) Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
Table 6. Infant Formula Major Manufacturers
Table 7. Functional Food & Beverages Major Manufacturers
Table 8. Food/Medical Supplements Major Manufacturers
Table 9. Others Major Manufacturers
Table 10. Human Milk Oligosaccharides (HMO) Industry Trends
Table 11. Human Milk Oligosaccharides (HMO) Industry Drivers
Table 12. Human Milk Oligosaccharides (HMO) Industry Opportunities and Challenges
Table 13. Human Milk Oligosaccharides (HMO) Industry Restraints
Table 14. Global Human Milk Oligosaccharides (HMO) Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 15. Global Human Milk Oligosaccharides (HMO) Revenue by Region (2019-2024) & (US$ Million)
Table 16. Global Human Milk Oligosaccharides (HMO) Revenue by Region (2025-2030) & (US$ Million)
Table 17. Global Human Milk Oligosaccharides (HMO) Revenue Market Share by Region (2019-2024)
Table 18. Global Human Milk Oligosaccharides (HMO) Revenue Market Share by Region (2025-2030)
Table 19. Global Human Milk Oligosaccharides (HMO) Sales Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (Tons)
Table 20. Global Human Milk Oligosaccharides (HMO) Sales by Region (2019-2024) & (Tons)
Table 21. Global Human Milk Oligosaccharides (HMO) Sales by Region (2025-2030) & (Tons)
Table 22. Global Human Milk Oligosaccharides (HMO) Sales Market Share by Region (2019-2024)
Table 23. Global Human Milk Oligosaccharides (HMO) Sales Market Share by Region (2025-2030)
Table 24. Global Human Milk Oligosaccharides (HMO) Revenue by Manufacturers (US$ Million) & (2019-2024)
Table 25. Global Human Milk Oligosaccharides (HMO) Revenue Market Share by Manufacturers (2019-2024)
Table 26. Global Human Milk Oligosaccharides (HMO) Sales by Manufacturers (US$ Million) & (2019-2024)
Table 27. Global Human Milk Oligosaccharides (HMO) Sales Market Share by Manufacturers (2019-2024)
Table 28. Global Human Milk Oligosaccharides (HMO) Sales Price (USD/Ton) of Manufacturers (2019-2024)
Table 29. Global Human Milk Oligosaccharides (HMO) Key Manufacturers Ranking, 2022 VS 2023 VS 2024
Table 30. Global Human Milk Oligosaccharides (HMO) Key Manufacturers Manufacturing Sites & Headquarters
Table 31. Global Human Milk Oligosaccharides (HMO) Manufacturers, Product Type & Application
Table 32. Global Human Milk Oligosaccharides (HMO) Manufacturers Commercialization Time
Table 33. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 34. Global Human Milk Oligosaccharides (HMO) by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2023)
Table 35. Global Human Milk Oligosaccharides (HMO) Revenue by Type 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Global Human Milk Oligosaccharides (HMO) Revenue by Type (2019-2024) & (US$ Million)
Table 37. Global Human Milk Oligosaccharides (HMO) Revenue by Type (2025-2030) & (US$ Million)
Table 38. Global Human Milk Oligosaccharides (HMO) Revenue Market Share by Type (2019-2024)
Table 39. Global Human Milk Oligosaccharides (HMO) Revenue Market Share by Type (2025-2030)
Table 40. Global Human Milk Oligosaccharides (HMO) Sales by Type 2019 VS 2023 VS 2030 (Tons)
Table 41. Global Human Milk Oligosaccharides (HMO) Sales by Type (2019-2024) & (Tons)
Table 42. Global Human Milk Oligosaccharides (HMO) Sales by Type (2025-2030) & (Tons)
Table 43. Global Human Milk Oligosaccharides (HMO) Sales Market Share by Type (2019-2024)
Table 44. Global Human Milk Oligosaccharides (HMO) Sales Market Share by Type (2025-2030)
Table 45. Global Human Milk Oligosaccharides (HMO) Price by Type (2019-2024) & (USD/Ton)
Table 46. Global Human Milk Oligosaccharides (HMO) Price by Type (2025-2030) & (USD/Ton)
Table 47. Global Human Milk Oligosaccharides (HMO) Revenue by Application 2019 VS 2023 VS 2030 (US$ Million)
Table 48. Global Human Milk Oligosaccharides (HMO) Revenue by Application (2019-2024) & (US$ Million)
Table 49. Global Human Milk Oligosaccharides (HMO) Revenue by Application (2025-2030) & (US$ Million)
Table 50. Global Human Milk Oligosaccharides (HMO) Revenue Market Share by Application (2019-2024)
Table 51. Global Human Milk Oligosaccharides (HMO) Revenue Market Share by Application (2025-2030)
Table 52. Global Human Milk Oligosaccharides (HMO) Sales by Application 2019 VS 2023 VS 2030 (Tons)
Table 53. Global Human Milk Oligosaccharides (HMO) Sales by Application (2019-2024) & (Tons)
Table 54. Global Human Milk Oligosaccharides (HMO) Sales by Application (2025-2030) & (Tons)
Table 55. Global Human Milk Oligosaccharides (HMO) Sales Market Share by Application (2019-2024)
Table 56. Global Human Milk Oligosaccharides (HMO) Sales Market Share by Application (2025-2030)
Table 57. Global Human Milk Oligosaccharides (HMO) Price by Application (2019-2024) & (USD/Ton)
Table 58. Global Human Milk Oligosaccharides (HMO) Price by Application (2025-2030) & (USD/Ton)
Table 59. Abbott Company Information
Table 60. Abbott Business Overview
Table 61. Abbott Human Milk Oligosaccharides (HMO) Sales (Tons), Revenue (US$ Million), Price (USD/Ton) and Gross Margin (2019-2024)
Table 62. Abbott Human Milk Oligosaccharides (HMO) Product Portfolio
Table 63. Abbott Recent Development
Table 64. Inbiose Company Information
Table 65. Inbiose Business Overview
Table 66. Inbiose Human Milk Oligosaccharides (HMO) Sales (Tons), Revenue (US$ Million), Price (USD/Ton) and Gross Margin (2019-2024)
Table 67. Inbiose Human Milk Oligosaccharides (HMO) Product Portfolio
Table 68. Inbiose Recent Development
Table 69. Glycom Company Information
Table 70. Glycom Business Overview
Table 71. Glycom Human Milk Oligosaccharides (HMO) Sales (Tons), Revenue (US$ Million), Price (USD/Ton) and Gross Margin (2019-2024)
Table 72. Glycom Human Milk Oligosaccharides (HMO) Product Portfolio
Table 73. Glycom Recent Development
Table 74. Chr. Hansen (Jennewein) Company Information
Table 75. Chr. Hansen (Jennewein) Business Overview
Table 76. Chr. Hansen (Jennewein) Human Milk Oligosaccharides (HMO) Sales (Tons), Revenue (US$ Million), Price (USD/Ton) and Gross Margin (2019-2024)
Table 77. Chr. Hansen (Jennewein) Human Milk Oligosaccharides (HMO) Product Portfolio
Table 78. Chr. Hansen (Jennewein) Recent Development
Table 79. Elicityl SA Company Information
Table 80. Elicityl SA Business Overview
Table 81. Elicityl SA Human Milk Oligosaccharides (HMO) Sales (Tons), Revenue (US$ Million), Price (USD/Ton) and Gross Margin (2019-2024)
Table 82. Elicityl SA Human Milk Oligosaccharides (HMO) Product Portfolio
Table 83. Elicityl SA Recent Development
Table 84. ZuChem Company Information
Table 85. ZuChem Business Overview
Table 86. ZuChem Human Milk Oligosaccharides (HMO) Sales (Tons), Revenue (US$ Million), Price (USD/Ton) and Gross Margin (2019-2024)
Table 87. ZuChem Human Milk Oligosaccharides (HMO) Product Portfolio
Table 88. ZuChem Recent Development
Table 89. Dextra Laboratories Company Information
Table 90. Dextra Laboratories Business Overview
Table 91. Dextra Laboratories Human Milk Oligosaccharides (HMO) Sales (Tons), Revenue (US$ Million), Price (USD/Ton) and Gross Margin (2019-2024)
Table 92. Dextra Laboratories Human Milk Oligosaccharides (HMO) Product Portfolio
Table 93. Dextra Laboratories Recent Development
Table 94. North America Human Milk Oligosaccharides (HMO) Revenue by Type (2019-2024) & (US$ Million)
Table 95. North America Human Milk Oligosaccharides (HMO) Revenue by Type (2025-2030) & (US$ Million)
Table 96. North America Human Milk Oligosaccharides (HMO) Sales by Type (2019-2024) & (Tons)
Table 97. North America Human Milk Oligosaccharides (HMO) Sales by Type (2025-2030) & (Tons)
Table 98. North America Human Milk Oligosaccharides (HMO) Sales Price by Type (2019-2024) & (USD/Ton)
Table 99. North America Human Milk Oligosaccharides (HMO) Sales Price by Type (2025-2030) & (USD/Ton)
Table 100. North America Human Milk Oligosaccharides (HMO) Revenue by Application (2019-2024) & (US$ Million)
Table 101. North America Human Milk Oligosaccharides (HMO) Revenue by Application (2025-2030) & (US$ Million)
Table 102. North America Human Milk Oligosaccharides (HMO) Sales by Application (2019-2024) & (Tons)
Table 103. North America Human Milk Oligosaccharides (HMO) Sales by Application (2025-2030) & (Tons)
Table 104. North America Human Milk Oligosaccharides (HMO) Sales Price by Application (2019-2024) & (USD/Ton)
Table 105. North America Human Milk Oligosaccharides (HMO) Sales Price by Application (2025-2030) & (USD/Ton)
Table 106. North America Human Milk Oligosaccharides (HMO) Revenue Grow Rate by Country (2019 VS 2023 VS 2030) & (US$ Million)
Table 107. North America Human Milk Oligosaccharides (HMO) Revenue Grow Rate by Country (2019-2024) & (US$ Million)
Table 108. North America Human Milk Oligosaccharides (HMO) Revenue Grow Rate by Country (2025-2030) & (US$ Million)
Table 109. North America Human Milk Oligosaccharides (HMO) Sales by Country (2019 VS 2023 VS 2030) & (Tons)
Table 110. North America Human Milk Oligosaccharides (HMO) Sales by Country (2019-2024) & (Tons)
Table 111. North America Human Milk Oligosaccharides (HMO) Sales by Country (2025-2030) & (Tons)
Table 112. North America Human Milk Oligosaccharides (HMO) Sales Price by Country (2019-2024) & (USD/Ton)
Table 113. North America Human Milk Oligosaccharides (HMO) Sales Price by Country (2025-2030) & (USD/Ton)
Table 114. US Human Milk Oligosaccharides (HMO) Revenue (2019-2030) & (US$ Million)
Table 115. Canada Human Milk Oligosaccharides (HMO) Revenue (2019-2030) & (US$ Million)
Table 116. Europe Human Milk Oligosaccharides (HMO) Revenue by Type (2019-2024) & (US$ Million)
Table 117. Europe Human Milk Oligosaccharides (HMO) Revenue by Type (2025-2030) & (US$ Million)
Table 118. Europe Human Milk Oligosaccharides (HMO) Sales by Type (2019-2024) & (Tons)
Table 119. Europe Human Milk Oligosaccharides (HMO) Sales by Type (2025-2030) & (Tons)
Table 120. Europe Human Milk Oligosaccharides (HMO) Sales Price by Type (2019-2024) & (USD/Ton)
Table 121. Europe Human Milk Oligosaccharides (HMO) Sales Price by Type (2025-2030) & (USD/Ton)
Table 122. Europe Human Milk Oligosaccharides (HMO) Revenue by Application (2019-2024) & (US$ Million)
Table 123. Europe Human Milk Oligosaccharides (HMO) Revenue by Application (2025-2030) & (US$ Million)
Table 124. Europe Human Milk Oligosaccharides (HMO) Sales by Application (2019-2024) & (Tons)
Table 125. Europe Human Milk Oligosaccharides (HMO) Sales by Application (2025-2030) & (Tons)
Table 126. Europe Human Milk Oligosaccharides (HMO) Sales Price by Application (2019-2024) & (USD/Ton)
Table 127. Europe Human Milk Oligosaccharides (HMO) Sales Price by Application (2025-2030) & (USD/Ton)
Table 128. Europe Human Milk Oligosaccharides (HMO) Revenue Grow Rate by Country (2019 VS 2023 VS 2030) & (US$ Million)
Table 129. Europe Human Milk Oligosaccharides (HMO) Revenue Grow Rate by Country (2019-2024) & (US$ Million)
Table 130. Europe Human Milk Oligosaccharides (HMO) Revenue Grow Rate by Country (2025-2030) & (US$ Million)
Table 131. Europe Human Milk Oligosaccharides (HMO) Sales by Country (2019 VS 2023 VS 2030) & (Tons)
Table 132. Europe Human Milk Oligosaccharides (HMO) Sales by Country (2019-2024) & (Tons)
Table 133. Europe Human Milk Oligosaccharides (HMO) Sales by Country (2025-2030) & (Tons)
Table 134. Europe Human Milk Oligosaccharides (HMO) Sales Price by Country (2019-2024) & (USD/Ton)
Table 135. Europe Human Milk Oligosaccharides (HMO) Sales Price by Country (2025-2030) & (USD/Ton)
Table 136. Germany Human Milk Oligosaccharides (HMO) Revenue (2019-2030) & (US$ Million)
Table 137. France Human Milk Oligosaccharides (HMO) Revenue (2019-2030) & (US$ Million)
Table 138. Human Milk Oligosaccharides (HMO) Revenue (2019-2030) & (US$ Million)
Table 139. Human Milk Oligosaccharides (HMO) Revenue (2019-2030) & (US$ Million)
Table 140. Human Milk Oligosaccharides (HMO) Revenue (2019-2030) & (US$ Million)
Table 141. China Human Milk Oligosaccharides (HMO) Revenue by Type (2019-2024) & (US$ Million)
Table 142. China Human Milk Oligosaccharides (HMO) Revenue by Type (2025-2030) & (US$ Million)
Table 143. China Human Milk Oligosaccharides (HMO) Sales by Type (2019-2024) & (Tons)
Table 144. China Human Milk Oligosaccharides (HMO) Sales by Type (2025-2030) & (Tons)
Table 145. China Human Milk Oligosaccharides (HMO) Sales Price by Type (2019-2024) & (USD/Ton)
Table 146. China Human Milk Oligosaccharides (HMO) Sales Price by Type (2025-2030) & (USD/Ton)
Table 147. China Human Milk Oligosaccharides (HMO) Revenue by Application (2019-2024) & (US$ Million)
Table 148. China Human Milk Oligosaccharides (HMO) Revenue by Application (2025-2030) & (US$ Million)
Table 149. China Human Milk Oligosaccharides (HMO) Sales by Application (2019-2024) & (Tons)
Table 150. China Human Milk Oligosaccharides (HMO) Sales by Application (2025-2030) & (Tons)
Table 151. China Human Milk Oligosaccharides (HMO) Sales Price by Application (2019-2024) & (USD/Ton)
Table 152. China Human Milk Oligosaccharides (HMO) Sales Price by Application (2025-2030) & (USD/Ton)
Table 153. Asia Human Milk Oligosaccharides (HMO) Revenue by Type (2019-2024) & (US$ Million)
Table 154. Asia Human Milk Oligosaccharides (HMO) Revenue by Type (2025-2030) & (US$ Million)
Table 155. Asia Human Milk Oligosaccharides (HMO) Sales by Type (2019-2024) & (Tons)
Table 156. Asia Human Milk Oligosaccharides (HMO) Sales by Type (2025-2030) & (Tons)
Table 157. Asia Human Milk Oligosaccharides (HMO) Sales Price by Type (2019-2024) & (USD/Ton)
Table 158. Asia Human Milk Oligosaccharides (HMO) Sales Price by Type (2025-2030) & (USD/Ton)
Table 159. Asia Human Milk Oligosaccharides (HMO) Revenue by Application (2019-2024) & (US$ Million)
Table 160. Asia Human Milk Oligosaccharides (HMO) Revenue by Application (2025-2030) & (US$ Million)
Table 161. Asia Human Milk Oligosaccharides (HMO) Sales by Application (2019-2024) & (Tons)
Table 162. Asia Human Milk Oligosaccharides (HMO) Sales by Application (2025-2030) & (Tons)
Table 163. Asia Human Milk Oligosaccharides (HMO) Sales Price by Application (2019-2024) & (USD/Ton)
Table 164. Asia Human Milk Oligosaccharides (HMO) Sales Price by Application (2025-2030) & (USD/Ton)
Table 165. Asia Human Milk Oligosaccharides (HMO) Revenue Grow Rate by Country (2019 VS 2023 VS 2030) & (US$ Million)
Table 166. Asia Human Milk Oligosaccharides (HMO) Revenue Grow Rate by Country (2019-2024) & (US$ Million)
Table 167. Asia Human Milk Oligosaccharides (HMO) Revenue Grow Rate by Country (2025-2030) & (US$ Million)
Table 168. Asia Human Milk Oligosaccharides (HMO) Sales by Country (2019 VS 2023 VS 2030) & (Tons)
Table 169. Asia Human Milk Oligosaccharides (HMO) Sales by Country (2019-2024) & (Tons)
Table 170. Asia Human Milk Oligosaccharides (HMO) Sales by Country (2025-2030) & (Tons)
Table 171. Asia Human Milk Oligosaccharides (HMO) Sales Price by Country (2019-2024) & (USD/Ton)
Table 172. Asia Human Milk Oligosaccharides (HMO) Sales Price by Country (2025-2030) & (USD/Ton)
Table 173. Japan Human Milk Oligosaccharides (HMO) Revenue (2019-2030) & (US$ Million)
Table 174. South Korea Human Milk Oligosaccharides (HMO) Revenue (2019-2030) & (US$ Million)
Table 175. Human Milk Oligosaccharides (HMO) Revenue (2019-2030) & (US$ Million)
Table 176. Human Milk Oligosaccharides (HMO) Revenue (2019-2030) & (US$ Million)
Table 177. Human Milk Oligosaccharides (HMO) Revenue (2019-2030) & (US$ Million)
Table 178. Human Milk Oligosaccharides (HMO) Revenue (2019-2030) & (US$ Million)
Table 179. Human Milk Oligosaccharides (HMO) Revenue (2019-2030) & (US$ Million)
Table 180. Human Milk Oligosaccharides (HMO) Revenue (2019-2030) & (US$ Million)
Table 181. MEALA Human Milk Oligosaccharides (HMO) Revenue by Type (2019-2024) & (US$ Million)
Table 182. MEALA Human Milk Oligosaccharides (HMO) Revenue by Type (2025-2030) & (US$ Million)
Table 183. MEALA Human Milk Oligosaccharides (HMO) Sales by Type (2019-2024) & (Tons)
Table 184. MEALA Human Milk Oligosaccharides (HMO) Sales by Type (2025-2030) & (Tons)
Table 185. MEALA Human Milk Oligosaccharides (HMO) Sales Price by Type (2019-2024) & (USD/Ton)
Table 186. MEALA Human Milk Oligosaccharides (HMO) Sales Price by Type (2025-2030) & (USD/Ton)
Table 187. MEALA Human Milk Oligosaccharides (HMO) Revenue by Application (2019-2024) & (US$ Million)
Table 188. MEALA Human Milk Oligosaccharides (HMO) Revenue by Application (2025-2030) & (US$ Million)
Table 189. MEALA Human Milk Oligosaccharides (HMO) Sales by Application (2019-2024) & (Tons)
Table 190. MEALA Human Milk Oligosaccharides (HMO) Sales by Application (2025-2030) & (Tons)
Table 191. MEALA Human Milk Oligosaccharides (HMO) Sales Price by Application (2019-2024) & (USD/Ton)
Table 192. MEALA Human Milk Oligosaccharides (HMO) Sales Price by Application (2025-2030) & (USD/Ton)
Table 193. MEALA Human Milk Oligosaccharides (HMO) Revenue Grow Rate by Country (2019 VS 2023 VS 2030) & (US$ Million)
Table 194. MEALA Human Milk Oligosaccharides (HMO) Revenue Grow Rate by Country (2019-2024) & (US$ Million)
Table 195. MEALA Human Milk Oligosaccharides (HMO) Revenue Grow Rate by Country (2025-2030) & (US$ Million)
Table 196. MEALA Human Milk Oligosaccharides (HMO) Sales by Country (2019 VS 2023 VS 2030) & (Tons)
Table 197. MEALA Human Milk Oligosaccharides (HMO) Sales by Country (2019-2024) & (Tons)
Table 198. MEALA Human Milk Oli
